Header Logo

Reina Haque

Concepts (326)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
33
2025
913
5.820
Why?
Cancer Survivors
6
2025
114
3.610
Why?
Prostatic Neoplasms
13
2022
196
2.740
Why?
Tamoxifen
9
2016
52
2.340
Why?
Neoplasm Recurrence, Local
14
2024
222
1.930
Why?
Aromatase Inhibitors
6
2016
34
1.850
Why?
Survivors
10
2022
154
1.710
Why?
Neoplasms, Second Primary
3
2025
29
1.700
Why?
Aged
57
2025
5901
1.660
Why?
Humans
81
2025
16832
1.570
Why?
Antineoplastic Agents, Hormonal
7
2017
56
1.530
Why?
Middle Aged
58
2025
7515
1.520
Why?
Neoplasms
3
2023
447
1.260
Why?
Androgen Antagonists
5
2017
12
1.250
Why?
Female
49
2025
12193
1.250
Why?
California
23
2025
2244
1.200
Why?
Proportional Hazards Models
14
2025
657
1.150
Why?
Cardiovascular Diseases
6
2017
520
1.100
Why?
Retrospective Studies
16
2025
2463
1.040
Why?
Depressive Disorder
2
2022
177
0.980
Why?
Adult
33
2025
7255
0.950
Why?
Risk Factors
21
2025
3108
0.950
Why?
Neoplasm Staging
14
2025
322
0.940
Why?
Chemoradiotherapy
1
2025
1
0.940
Why?
Antineoplastic Agents, Immunological
1
2025
10
0.930
Why?
Antibodies, Monoclonal
1
2025
24
0.920
Why?
Aged, 80 and over
21
2025
1887
0.890
Why?
Carcinoma, Non-Small-Cell Lung
1
2025
51
0.880
Why?
Health Maintenance Organizations
4
2017
358
0.800
Why?
CA-125 Antigen
2
2020
6
0.790
Why?
Membrane Proteins
2
2020
29
0.780
Why?
Male
39
2025
9556
0.770
Why?
Ovarian Neoplasms
2
2020
53
0.750
Why?
Analgesics, Opioid
1
2025
239
0.720
Why?
Opioid-Related Disorders
1
2025
174
0.720
Why?
Lung Neoplasms
1
2025
268
0.710
Why?
Paroxetine
2
2015
12
0.690
Why?
Health Services Accessibility
1
2023
262
0.640
Why?
Depression
3
2022
479
0.640
Why?
Cohort Studies
20
2022
2396
0.630
Why?
Obesity
4
2021
811
0.600
Why?
Insurance, Health
1
2021
167
0.600
Why?
Healthcare Disparities
1
2021
213
0.550
Why?
Patient Compliance
3
2020
262
0.550
Why?
Follow-Up Studies
12
2025
1058
0.550
Why?
Endometrial Neoplasms
2
2015
37
0.550
Why?
Arrhythmias, Cardiac
1
2017
23
0.520
Why?
Protein Kinase Inhibitors
1
2017
3
0.510
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2017
3
0.510
Why?
Comorbidity
5
2025
516
0.500
Why?
Prognosis
11
2022
568
0.480
Why?
Sigmoidoscopy
2
2007
61
0.470
Why?
Antidepressive Agents, Second-Generation
1
2015
17
0.460
Why?
Algorithms
4
2020
210
0.460
Why?
Pathology Department, Hospital
1
2015
2
0.450
Why?
Overweight
2
2021
262
0.440
Why?
Diphosphonates
1
2016
63
0.440
Why?
Lymphoma, Large B-Cell, Diffuse
4
2017
15
0.440
Why?
Medication Adherence
2
2017
235
0.440
Why?
Carcinoma, Intraductal, Noninfiltrating
5
2015
30
0.440
Why?
Treatment Outcome
9
2025
1098
0.430
Why?
Radiotherapy, Adjuvant
4
2016
12
0.420
Why?
Biomarkers, Tumor
4
2020
130
0.410
Why?
Research Design
1
2015
319
0.380
Why?
Multivariate Analysis
4
2021
489
0.370
Why?
Urinary Bladder Neoplasms
2
2024
53
0.370
Why?
Arsenic
4
2007
5
0.370
Why?
Antidepressive Agents
2
2022
140
0.370
Why?
Social Class
3
2023
106
0.360
Why?
Sleep Wake Disorders
1
2012
31
0.350
Why?
Inflammation
1
2012
56
0.350
Why?
Neoplasm Grading
4
2017
43
0.350
Why?
Mass Screening
2
2009
670
0.350
Why?
Heart Failure
1
2017
403
0.350
Why?
Prostate-Specific Antigen
3
2016
64
0.350
Why?
Prospective Studies
11
2024
1186
0.350
Why?
Risk Reduction Behavior
1
2012
97
0.340
Why?
Continental Population Groups
2
2009
255
0.340
Why?
Registries
7
2021
449
0.330
Why?
Socioeconomic Factors
3
2023
571
0.320
Why?
Body Mass Index
3
2013
925
0.320
Why?
Carcinoma, Ductal
1
2010
2
0.320
Why?
Preventive Health Services
1
2012
142
0.320
Why?
Cross-Sectional Studies
10
2012
1233
0.310
Why?
United States
8
2025
3858
0.310
Why?
Risk
6
2020
453
0.310
Why?
Case-Control Studies
13
2015
995
0.300
Why?
Electronic Health Records
1
2015
702
0.300
Why?
Prostatectomy
5
2016
68
0.290
Why?
Incidence
9
2015
1229
0.290
Why?
Prostate
2
2022
23
0.280
Why?
Managed Care Programs
1
2010
275
0.280
Why?
Drug Administration Schedule
3
2025
94
0.270
Why?
Gonadotropin-Releasing Hormone
3
2017
6
0.270
Why?
Water Supply
3
2007
8
0.270
Why?
Environmental Exposure
4
2007
120
0.270
Why?
Practice Patterns, Physicians'
1
2010
290
0.260
Why?
Insurance Carriers
1
2007
4
0.260
Why?
Organizations, Nonprofit
1
2007
8
0.260
Why?
Age Factors
4
2025
814
0.250
Why?
Keratosis
2
2004
2
0.250
Why?
Salvage Therapy
2
2016
13
0.250
Why?
Colorectal Neoplasms
3
2010
635
0.240
Why?
Longitudinal Studies
3
2022
653
0.230
Why?
Ethnic Groups
2
2021
418
0.230
Why?
Young Adult
6
2022
2456
0.230
Why?
HIV Infections
3
2017
708
0.220
Why?
Survivorship
1
2025
13
0.220
Why?
Survival Rate
4
2014
247
0.220
Why?
Odds Ratio
6
2017
569
0.220
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
3
2015
155
0.220
Why?
Receptor, ErbB-2
2
2016
39
0.220
Why?
Sensitivity and Specificity
4
2020
291
0.220
Why?
Mitomycin
1
2024
4
0.210
Why?
Isothiocyanates
1
2024
8
0.210
Why?
BCG Vaccine
1
2024
8
0.210
Why?
Logistic Models
7
2013
796
0.200
Why?
Ultrasonography
2
2020
32
0.200
Why?
Hyperpigmentation
1
2003
1
0.190
Why?
Early Detection of Cancer
3
2020
553
0.190
Why?
Colonoscopy
1
2005
261
0.190
Why?
Lower Urinary Tract Symptoms
2
2013
8
0.180
Why?
Electronic Nicotine Delivery Systems
1
2022
27
0.180
Why?
Breast
1
2022
66
0.180
Why?
Hallucinogens
1
2022
21
0.180
Why?
Hip Fractures
2
2015
72
0.180
Why?
Arsenic Poisoning
3
2007
3
0.170
Why?
Depressive Disorder, Major
1
2022
95
0.170
Why?
Sleep
1
2021
54
0.170
Why?
Feasibility Studies
2
2020
108
0.170
Why?
Mammography
3
2012
141
0.170
Why?
Chemotherapy, Adjuvant
4
2015
79
0.170
Why?
Cannabis
1
2022
79
0.160
Why?
Erectile Dysfunction
2
2011
18
0.160
Why?
Watchful Waiting
1
2020
19
0.150
Why?
Wine
2
2010
17
0.150
Why?
Adolescent
5
2017
3464
0.150
Why?
Carcinoma in Situ
2
2009
12
0.150
Why?
Survival Analysis
2
2017
191
0.150
Why?
Pilot Projects
1
2020
210
0.150
Why?
Carcinoma, Ductal, Breast
2
2009
42
0.150
Why?
India
7
2012
12
0.140
Why?
Kaplan-Meier Estimate
3
2015
110
0.140
Why?
Receptors, Estrogen
2
2016
46
0.140
Why?
Neoplasm Invasiveness
5
2024
69
0.140
Why?
Diabetes Mellitus
2
2014
445
0.140
Why?
Disease-Free Survival
2
2015
54
0.140
Why?
Cell Cycle Proteins
2
2015
7
0.130
Why?
Apoptosis
2
2015
11
0.130
Why?
Exercise
1
2022
513
0.130
Why?
Leuprolide
1
2017
1
0.130
Why?
Goserelin
1
2017
1
0.130
Why?
Imidazolidines
1
2017
1
0.130
Why?
Flutamide
1
2017
2
0.130
Why?
Anilides
1
2017
2
0.130
Why?
Tosyl Compounds
1
2017
2
0.130
Why?
Nitriles
1
2017
7
0.130
Why?
Hospitalization
1
2023
816
0.130
Why?
Vaccination
1
2023
725
0.130
Why?
Skin Diseases
3
2005
11
0.130
Why?
Antineoplastic Agents
2
2015
58
0.130
Why?
Time Factors
6
2013
989
0.130
Why?
Clinical Laboratory Services
1
2016
1
0.130
Why?
Delivery of Health Care, Integrated
2
2021
515
0.130
Why?
Medical Records
2
2008
85
0.120
Why?
Water Pollutants, Chemical
2
2007
6
0.120
Why?
Smoking
3
2022
373
0.120
Why?
Administration, Oral
1
2016
81
0.120
Why?
Disease Progression
1
2017
252
0.120
Why?
Medroxyprogesterone Acetate
1
2015
15
0.120
Why?
Forecasting
1
2016
67
0.120
Why?
Immunohistochemistry
4
2017
41
0.120
Why?
T-Lymphocyte Subsets
1
2015
4
0.120
Why?
CD8-Positive T-Lymphocytes
1
2015
5
0.120
Why?
Macrophages
1
2015
8
0.120
Why?
Health Resources
1
2015
35
0.110
Why?
European Continental Ancestry Group
3
2012
400
0.110
Why?
Nomograms
1
2015
11
0.110
Why?
Estrogen Replacement Therapy
1
2015
91
0.110
Why?
SEER Program
4
2017
86
0.110
Why?
Apoptosis Regulatory Proteins
1
2015
4
0.110
Why?
Lymphocyte Activation
1
2015
6
0.110
Why?
Mastectomy, Segmental
2
2012
15
0.110
Why?
Prevalence
6
2014
785
0.100
Why?
Health Behavior
2
2015
332
0.100
Why?
Oncogene Proteins, Fusion
1
2013
2
0.100
Why?
Trans-Activators
1
2013
7
0.100
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2011
57
0.100
Why?
Predictive Value of Tests
1
2014
325
0.090
Why?
Life Style
2
2012
305
0.090
Why?
Men's Health
2
2009
14
0.090
Why?
Epstein-Barr Virus Infections
1
2012
4
0.090
Why?
Dose-Response Relationship, Drug
3
2015
110
0.090
Why?
Fractures, Bone
1
2013
92
0.090
Why?
Lymphoma, AIDS-Related
1
2012
18
0.090
Why?
Gene Expression Regulation, Neoplastic
1
2012
40
0.090
Why?
Clinical Trials as Topic
1
2012
114
0.090
Why?
Acquired Immunodeficiency Syndrome
1
2012
58
0.090
Why?
Asian Continental Ancestry Group
1
2012
69
0.090
Why?
Health Care Surveys
1
2012
201
0.080
Why?
Health Status
2
2009
256
0.080
Why?
Mammary Glands, Human
1
2010
5
0.080
Why?
Medical Audit
1
2010
31
0.080
Why?
Massachusetts
1
2010
58
0.080
Why?
Health Status Disparities
1
2011
145
0.080
Why?
Prostatitis
1
2010
3
0.080
Why?
Sexually Transmitted Diseases
1
2010
53
0.070
Why?
Family Characteristics
1
2009
69
0.070
Why?
Educational Status
1
2009
163
0.070
Why?
Confounding Factors (Epidemiology)
1
2009
77
0.070
Why?
Bias
1
2009
90
0.070
Why?
Enzyme Inhibitors
1
2008
4
0.070
Why?
5-alpha Reductase Inhibitors
1
2008
5
0.070
Why?
Quality of Life
1
2012
477
0.070
Why?
Child
3
2022
2433
0.070
Why?
Population Surveillance
3
2016
242
0.070
Why?
Body Height
1
2008
54
0.070
Why?
Patient Education as Topic
1
2009
186
0.070
Why?
Risk Assessment
3
2020
1047
0.070
Why?
Residence Characteristics
1
2009
244
0.060
Why?
Body Weight
1
2008
197
0.060
Why?
Precancerous Conditions
1
2007
45
0.060
Why?
Fetal Development
1
2007
15
0.060
Why?
Cognition Disorders
1
2007
30
0.060
Why?
Diabetes Mellitus, Type 2
1
2013
677
0.060
Why?
Methionine
1
2005
5
0.060
Why?
Selenium
1
2005
4
0.060
Why?
Micronutrients
1
2005
9
0.060
Why?
beta Carotene
1
2005
17
0.060
Why?
Bronchiectasis
1
2005
2
0.060
Why?
Water
1
2005
3
0.060
Why?
Respiration Disorders
1
2005
5
0.060
Why?
Surveys and Questionnaires
4
2011
1204
0.060
Why?
Automation
1
2005
22
0.050
Why?
Nutrition Disorders
1
2004
1
0.050
Why?
Skin Pigmentation
1
2004
6
0.050
Why?
Antibiotics, Antineoplastic
1
2024
6
0.050
Why?
Adjuvants, Immunologic
1
2024
19
0.050
Why?
Biopsy
2
2017
74
0.050
Why?
Proto-Oncogene Proteins c-bcl-6
2
2015
6
0.050
Why?
DNA-Binding Proteins
2
2015
26
0.050
Why?
Rural Population
1
2003
58
0.050
Why?
Leukocytes, Mononuclear
1
2022
6
0.050
Why?
Telomere
1
2022
16
0.050
Why?
Diet
1
2024
349
0.040
Why?
Tumor Burden
2
2013
16
0.040
Why?
Ovary
1
2020
5
0.040
Why?
BRCA2 Protein
1
2020
5
0.040
Why?
BRCA1 Protein
1
2020
7
0.040
Why?
Heterozygote
1
2020
24
0.040
Why?
Mutation
1
2020
86
0.040
Why?
Gene Expression Regulation
1
2017
20
0.030
Why?
ROC Curve
1
2017
68
0.030
Why?
In Situ Hybridization, Fluorescence
1
2016
12
0.030
Why?
CD4 Lymphocyte Count
1
2017
182
0.030
Why?
Biomarkers
1
2017
284
0.030
Why?
Severity of Illness Index
2
2009
410
0.030
Why?
Hysterectomy
1
2015
19
0.030
Why?
Antigens, Differentiation, Myelomonocytic
1
2015
3
0.030
Why?
Forkhead Transcription Factors
1
2015
5
0.030
Why?
Reproducibility of Results
1
2016
346
0.030
Why?
Antigens, CD
1
2015
7
0.030
Why?
CD4-Positive T-Lymphocytes
1
2015
14
0.030
Why?
Double-Blind Method
1
2015
138
0.030
Why?
Proliferating Cell Nuclear Antigen
1
2015
3
0.030
Why?
Interferon Regulatory Factors
1
2015
3
0.030
Why?
Protein Kinase C beta
1
2015
3
0.030
Why?
Hyaluronan Receptors
1
2015
4
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2015
5
0.030
Why?
Immunoglobulin M
1
2015
9
0.030
Why?
Women's Health
1
2015
178
0.030
Why?
Postmenopause
1
2015
243
0.030
Why?
Orchiectomy
1
2014
4
0.030
Why?
Neoplasms, Hormone-Dependent
1
2014
6
0.030
Why?
Neoadjuvant Therapy
1
2014
12
0.030
Why?
Michigan
1
2014
26
0.030
Why?
Myocardial Infarction
1
2015
215
0.030
Why?
Mortality
1
2014
116
0.020
Why?
Cause of Death
1
2014
171
0.020
Why?
Transcriptional Regulator ERG
1
2013
2
0.020
Why?
Positive Regulatory Domain I-Binding Factor 1
1
2012
3
0.020
Why?
Ki-1 Antigen
1
2012
3
0.020
Why?
B7-1 Antigen
1
2012
3
0.020
Why?
LIM Domain Proteins
1
2012
3
0.020
Why?
In Situ Hybridization
1
2012
4
0.020
Why?
Repressor Proteins
1
2012
10
0.020
Why?
Adaptor Proteins, Signal Transducing
1
2012
14
0.020
Why?
NF-kappa B
1
2012
9
0.020
Why?
Herpesvirus 4, Human
1
2012
6
0.020
Why?
Proto-Oncogene Proteins
1
2012
31
0.020
Why?
Asian Americans
1
2011
146
0.020
Why?
Patient Selection
1
2012
175
0.020
Why?
Hispanic Americans
1
2011
350
0.020
Why?
Lymphatic Metastasis
1
2009
28
0.020
Why?
Acculturation
1
2009
15
0.020
Why?
Mastectomy
1
2009
34
0.020
Why?
Combined Modality Therapy
1
2009
103
0.020
Why?
Language
1
2009
51
0.020
Why?
African Americans
1
2011
394
0.020
Why?
African Continental Ancestry Group
1
2009
117
0.020
Why?
Data Interpretation, Statistical
1
2009
67
0.020
Why?
Propensity Score
1
2009
78
0.020
Why?
Dutasteride
1
2008
1
0.020
Why?
Azasteroids
1
2008
1
0.020
Why?
Finasteride
1
2008
1
0.020
Why?
Recurrence
1
2009
149
0.020
Why?
Adrenergic alpha-Antagonists
1
2008
7
0.020
Why?
Health Services Research
1
2009
180
0.020
Why?
Prostatic Hyperplasia
1
2008
20
0.020
Why?
Receptors, Progesterone
1
2008
43
0.020
Why?
Confidence Intervals
1
2008
207
0.020
Why?
Age Distribution
1
2008
221
0.020
Why?
Intelligence Tests
1
2007
3
0.020
Why?
Exanthema
1
2007
6
0.020
Why?
Epidemiological Monitoring
1
2007
21
0.020
Why?
Environmental Monitoring
1
2007
26
0.020
Why?
Statistics, Nonparametric
1
2005
45
0.010
Why?
Alcohol Drinking
1
2008
298
0.010
Why?
Respiratory Function Tests
1
2005
26
0.010
Why?
Chi-Square Distribution
1
2005
129
0.010
Why?
Nutritional Status
1
2004
32
0.010
Why?
Tomography, X-Ray Computed
1
2005
203
0.010
Why?
Prenatal Exposure Delayed Effects
1
2007
206
0.010
Why?
Health Surveys
1
2004
226
0.010
Why?
Child, Preschool
1
2007
1430
0.010
Why?
Pregnancy
1
2007
1555
0.010
Why?
Concepts (326)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_
-->

© 2026 Kaiser Permanente

Your Privacy Choices